SCHEMBL9528281

SCHEMBL9528281

CCCCCCCCCCCCNC(=S)Nc1ccc(C#N)cc1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
KMT2A Q03164 6/20 0.55
HTT P42858 5/20 0.55
MEN1 O00255 3/20 0.55
MGLL Q99685 2/20 0.54
PKM P14618 1/20 0.53
IDO1 P14902 1/20 0.53
MAPT P10636 5/20 0.52
ALDH1A1 P00352 3/20 0.52
GAA P10253 3/20 0.52
NPSR1 Q6W5P4 1/20 0.52
CYP1A2 P05177 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
ALOX12 P18054 1/20 0.48
PABPC1 P11940 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9533117 1.00 LMNA (0.58) LMNASMN1; SMN2KMT2AHTTMEN1
SCHEMBL10513899 1.00 LMNA (0.58) LMNASMN1; SMN2KMT2AHTTMEN1
SCHEMBL17956746 1.00 LMNA (0.58) LMNASMN1; SMN2KMT2AHTTMEN1
SCHEMBL18695165 0.94 LMNA (0.66) LMNASMN1; SMN2KMT2AHTTMEN1
SCHEMBL9230075 0.93 IDO1 (0.60) LMNASMN1; SMN2KMT2AHTTMEN1
SCHEMBL1638316 0.87 NPC1 (0.54) LMNASMN1; SMN2KMT2AHTTMEN1
SCHEMBL7157543 0.83 EPHX1 (0.67) HTTMGLLALDH1A1
SCHEMBL17079618 0.83 EPHX1 (0.67) HTTMGLLALDH1A1
SCHEMBL8443237 0.82 LMNA (0.65) LMNASMN1; SMN2KMT2AHTTMEN1
SCHEMBL8391699 0.82 LMNA (0.65) LMNASMN1; SMN2KMT2AHTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10767112-B2 Methods of producing metal sulfides, metal selenides, and metal sulfides/selenides having controlled architectures using kinetic control THE TRUSTEES OF THE COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2020-09-08 US disclosed
US-10253256-B2 Use of sulfur and selenium compounds as precursors to nanostructured materials THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2019-04-09 US disclosed
CN-106103348-B The purposes of sulphur compound and selenium compound as the precursor of nano structural material 哥伦比亚大学(纽约)理事会 2018-07-31 CN disclosed
US-20170369779-A1 METHODS OF PRODUCING METAL SULFIDES, METAL SELENIDES, AND METAL SULFIDES/SELENIDES HAVING CONTROLLED ARCHITECTURES USING KINETIC CONTROL THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2017-12-28 US disclosed
CN-106103348-A Sulphur compound and selenium compound are as the purposes of the precursor of nano structural material 哥伦比亚大学(纽约)理事会 2016-11-09 CN disclosed
US-20160237345-A1 USE OF SULFUR AND SELENIUM COMPOUNDS AS PRECURSORS TO NANOSTRUCTURED MATERIALS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2016-08-18 US disclosed
US-20160237345-A1 USE OF SULFUR AND SELENIUM COMPOUNDS AS PRECURSORS TO NANOSTRUCTURED MATERIALS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2016-08-18 US disclosed
EP-3049370-A1 USE OF SULFUR AND SELENIUM COMPOUNDS AS PRECURSORS TO NANOSTRUCTURED MATERIALS The Trustees of Columbia University in the City of New York (US) 2016-08-03 EP disclosed
EP-0299533-B1 HIGH POTENCY SWEETENING AGENTS THE NUTRASWEET COMPANY (a Delaware corporation) (US) 1993-04-07 EP disclosed
WO-1989000563-A1 HIGH POTENCY SWEETENING AGENTS THE NUTRASWEET COMPANY (US) 1989-01-26 WO disclosed
EP-0299533-A2 High potency sweetening agents THE NUTRASWEET COMPANY (a Delaware corporation) (US) 1989-01-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10253256-B2 Use of sulfur and selenium compounds as precursors to nanostructured materials SCLY, TST, SOD1 LMNA 3945/4885SMN1; SMN2 90/4885KMT2A 4073/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.